⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7166987 | 1.00 | — | — | |
| SCHEMBL10482355 | 0.92 | — | — | |
| SCHEMBL880923 | 0.88 | — | — | |
| SCHEMBL4254639 | 0.86 | SIGMAR1 (0.34) | — | |
| SCHEMBL14653055 | 0.86 | SIGMAR1 (0.34) | — | |
| SCHEMBL4019383 | 0.82 | CHRM1 (0.35) | — | |
| SCHEMBL5389941 | 0.73 | — | — | |
| SCHEMBL2724110 | 0.73 | — | — | |
| SCHEMBL6996772 | 0.69 | — | — | |
| SCHEMBL8764248 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116162128-A | Nucleoside derivative for resisting virus infection and preparation method and application thereof | 知和(山东)大药厂有限公司 | 2023-05-26 | — | — | CN | disclosed |
| US-5621142-A | N-METHYLASPARATIC ACID ANTAGONIST | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1997-04-15 | — | — | US | disclosed |
| US-5621142-A | N-METHYLASPARATIC ACID ANTAGONIST | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1997-04-15 | — | — | US | disclosed |
| US-5621142-A | N-METHYLASPARATIC ACID ANTAGONIST | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1997-04-15 | — | — | US | disclosed |
| EP-0747348-A1 | AMINOALKYLCYCLOPROPANE DERIVATIVE | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1996-12-11 | — | — | EP | disclosed |
| EP-0747348-A1 | AMINOALKYLCYCLOPROPANE DERIVATIVE | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1996-12-11 | — | — | EP | disclosed |